Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ReposiTrak filings document a Nevada operating company that provides SaaS-based traceability, compliance, risk management, and supply chain applications for retailers, wholesalers, suppliers, and food manufacturers. Its Form 8-K disclosures record quarterly results and earnings-call materials, cash dividend declarations, share repurchase authorizations, and material commercial or financing agreements involving its subsidiary PC Group.
Governance filings cover director appointments, committee assignments, annual meeting voting results, executive compensation advisory votes, and common-stock matters. The disclosures also describe the company's product families, public-company governance framework, capital allocation actions, and regulatory context for food safety and supply chain compliance.
ReposiTrak (NASDAQ:TRAK) filed a routine Form 4 on 06/25/2025 disclosing CEO/Chair Randall K. Fields’ automatic Rule 10b5-1 sales of 7,500 common shares for about $150k in aggregate, leaving him with roughly 4.8 million shares across direct and indirect holdings. No change to control or overall ownership percentage.
ReposiTrak CEO Randall K. Fields reported multiple stock sales executed through a Rule 10b5-1 trading plan via his charitable LLC. The transactions occurred over three consecutive days:
- June 16, 2025: Sold 1,500 shares at avg. price of $20.53
- June 17, 2025: Sold 3,500 shares at avg. price of $20.16
- June 18, 2025: Sold 2,500 shares at avg. price of $20.38
Following these transactions, Fields maintains significant holdings: 3,683,955 shares directly owned and substantial indirect ownership through various entities including 615,260 shares via Riverview Financial Corp. The sales were executed to meet charitable commitments. Fields holds multiple roles as Director, 10% Owner, and CEO. Additionally, he has indirect beneficial ownership of Series B Preferred Stock through Riverview Financial Corp (531,432 shares) and his spouse (12,322 shares).